Sales & Marketing A philosophical look at market turn in the Age of AI, with J... John Holodnak, co-founder of Occam, discusses how AI is beginning to reshape career paths across life sciences.
News MSD's Sac-TMT delivers in first phase 3 readout MSD's TROP2-targeting antibody-drug conjugate sac-TMT, licensed from China's Kelun, has improved survival in a late-stage endometrial cancer trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
